A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer
Romualdo Barroso‐Sousa, Ian E. Krop, Lorenzo Trippa, Zhenying Tan‐Wasielewski, Tianyu Li, Wafa Osmani, Chelsea Andrews, Deborah Dillon, Edward T. Richardson, Ricardo Pastorello, Eric P. Winer, Elizabeth A. Mittendorf, Jennifer R. Bellon, Jonathan D. Schoenfeld, Sara M. Tolaney
Topics & Concepts
MedicinePembrolizumabInternal medicineBreast cancerMetastatic breast cancerOncologyClinical endpointDocetaxelCancerProgression-free survivalConfidence intervalRadiation therapySurgeryChemotherapyClinical trialImmunotherapyCancer Immunotherapy and BiomarkersBreast Cancer Treatment StudiesCancer Research and Treatments